Chemours (CC)

• Market cap: $2.15B
• 1 day: 5.11%
• 5 days: 2.86%
• 1 month: -14.44%
• 3 months: -23.24%
• 6 months: -20.18%
• Year to date: -13.82%
• 1 year: -45.97%
• 5 years: 57.55%
• 10 years: -30.94%
• Sector: Materials
• Industry: Chemicals & Allied Products

About: The Chemours Co is a provider of chemicals. It delivers customized solutions with a wide range of industrial and specialty chemicals products for various markets including coatings, plastics, refrigeration, air conditioning, etc. The company's operating segments include Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. It generates maximum revenue from the Titanium Technologies segment. The Titanium Technologies segment is a producer of TiO2 pigment, a premium white pigment used to deliver whiteness, brightness, opacity, durability, efficiency, and protection across a variety of applications. Geographically, the company derives a majority of its revenue from North America.

Employees: 6,000

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

268% more call options, than puts

Call options by funds: $71.5M | Put options by funds: $19.4M

46% more first-time investments, than exits

New positions opened: 79 | Existing positions closed: 54

39% more repeat investments, than reductions

Existing positions increased: 140 | Existing positions reduced: 101

4% more funds holding

Funds holding: 418 [Q3] → 433 (+15) [Q4]

2.29% more ownership

Funds ownership: 82.54% [Q3] → 84.83% (+2.29%) [Q4]

14% less capital invested

Capital invested by funds: $2.5B [Q3] → $2.14B (-$362M) [Q4]

17% less funds holding in top 10

Funds holding in top 10: 6 [Q3] → 5 (-1) [Q4]

Research analyst outlook

6 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $19 32% upside
• Avg. target: $23 59% upside
• High target: $27 88% upside

6 analyst ratings

• positive: 2 33%
• neutral: 4 67%
• negative: 0 0%

Barclays Michael Leithead 35% 1-year accuracy 7 / 20 met price target	32% upside $19	Equal-Weight Maintained	24 Feb 2025
BMO Capital John McNulty 36% 1-year accuracy 17 / 47 met price target	88% upside $27	Outperform Maintained	19 Feb 2025
Truist Securities Peter Osterland 0% 1-year accuracy 0 / 7 met price target	88% upside $27	Buy Initiated	28 Jan 2025
Morgan Stanley Vincent Andrews 50% 1-year accuracy 4 / 8 met price target	53% upside $22	Equal-Weight Maintained	13 Jan 2025
Mizuho John Roberts 34% 1-year accuracy 12 / 35 met price target	46% upside $21	Neutral Maintained	7 Jan 2025